Plasma viscosity in COVID-19 disease: a vital monitoring role.

Establishing the diagnostic and prognostic value of measuring plasma viscosity in patients suspected or confirmed as having COVID-19 is currently underway in several UK hospitals. This article provides an overview of progress in research and practice

This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.